Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  metformin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-20 of 20 for your search:
Start Over
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 74
Sponsor: NCI, Other
Protocol IDs: MA32, U10CA077202, CAN-NCIC-MA.32, CDR0000669788, NCIC-MA.32, NCT01101438
Metformin Pre-Surgical Pilot Study
Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Other
Protocol IDs: AAAD6525, NCT00930579
Metformin Combined With Chemotherapy for Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: AMCmedonc10/003, NCT01210911
Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SAKK 08/09, SWS-SAKK-08/09, CDR0000688789, EU-21084, NCT01243385
Effect of Metformin on Breast Cancer Metabolism
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EP-TSC-647, NCT01266486
A Trial of Metformin for Colorectal Cancer Risk Reduction Among Patients With a History of Colorectal Adenomas and Elevated Body Mass Index
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 35 to 80
Sponsor: NCI
Protocol IDs: NCI-2011-01744, UCI 10-31, 2010-7705, UCI09-13-01, P30CA062203, N01CN35160, NCT01312467
Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-03451, MAY10-15-03, MAYO-MAY10-15-03, CDR0000698069, NCT01447927
Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 19 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00243, CDR0000712087, UARIZ-UAZ10-16-01, 11-0211-04, UAZ10-16-01, N01CN35158, P30CA023074, NCT01433913
Exemestane-RAD001-Metformin
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-1239, NCI-2012-01164, NCT01627067
Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: Fudan BR2012-12, NCT01654185
Metformin and 5-fluorouracil for Refractory Colorectal Cancer.
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 16
Sponsor: Other
Protocol IDs: NP 273/12, NCT01941953
Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NP 96/2010, NCT01971034
The Impact of Obesity and Obesity Treatments on Breast Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0284, NCT00933309
Lapatinib With Sirolimus or Metformin
Phase: Phase I
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: 2009-0743, NCI-2011-00563, NCT01087983
Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 79
Sponsor: Other
Protocol IDs: Metformin Anticancer + Chemo, NCT01442870
Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: METFORMIN, NCT00897884
Metformin and Endometrial Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2009-0927, NCI-2012-01796, CBC 965712, NCT01205672
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository
Status: Closed
Age: 18 to 74
Sponsor: NCI, Other
Protocol IDs: NSABP MA.32.F, NSABP-NCIC-CTG-MA.32.F, NCT01286233
Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: Metformin NSCLC, NCT02109549
Start Over